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Abstract
Bacterial  plasmid DNA is often used in gene therapy application as a vector for delivering
recombinant genes into eukaryotic cells. In this work we study effect of plasmid DNA encoding
pro-angiogenic growth factors VEGF and FGF2 on cytokine production of human adipose derived
stem cells (ADSC). Adipose tissue contain progenitor and stem cells with angiogenic potential
which  are  considered  promising  cell  source  for  treating  ischemic  conditions.  Genetic
modification of human ADSC with recombinant plasmids encoding therapeutic growth factors
might change therapeutic potential of these cells. We report that genetic modification of ADSC
with recombinant plasmid pBud-VEGF-FGF2 results in expected increased of VEGF secretion and
also results in increase of IL-8 and MCP-1 secretion into culture medium.
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